Cargando…

PATH-20. METHYLATION ARRAY PROFILING OF PEDIATRIC BRAIN TUMORS; SINGLE CENTRE EXPERIENCE

BACKGROUND: Significant heterogeneity of pediatric brain tumors poses major challenge on diagnostics. Therefore, we aimed to evaluate feasibility of methylation array in the diagnostic process. METHODS: Methylation array (Infinium MethylationEPIC, Illumina) was performed on DNA extracted from fresh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zapotocky, Michal, Vicha, Ales, Krskova, Lenka, Zamecnik, Josef, Stolova, Lucie, Misove, Adela, Vanova, Katerina, Koblizek, Miroslav, Ramaswamy, Vijay, Jones, David, Sumerauer, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Pathology and Molecular Diagnosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715940/ http://dx.doi.org/10.1093/neuonc/noaa222.655

Ejemplares similares

HGG-31. UNIQUE BIOLOGICAL CHARACTERISTICS OF RADIATION-INDUCED GLIOMAS
por: Váňová, Kateřina, et al.
Publicado: (2020)

HGG-14. Molecular characterization of unique biological subgroups among H3 wild type high-grade gliomas
por: Vanova, Katerina, et al.
Publicado: (2022)

Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas
por: Adela, Misove, et al.
Publicado: (2022)

Correction to: Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas
por: Misove, Adela, et al.
Publicado: (2022)

LGG-46. MOLECULAR CHARACTERIZATION OF HEMISPHERIC LOW-GRADE GLIOMAS IN CHILDREN
por: Mišove, Adéla, et al.
Publicado: (2020)

DIPG-like MYB-altered diffuse astrocytoma with durable response to intensive chemotherapy
por: Trkova, Katerina, et al.
Publicado: (2023)

SURG-05. Survival and functional outcomes in pediatric thalamic and thalamopeduncular low grade gliomas
por: Benes, Vladimir, et al.
Publicado: (2022)

LGG-07. TARGETED THERAPY IN PEDIATRIC LOW-GRADE GLIOMAS; REAL WORLD DATA IN THE CONTEXT OF CONVENTIONAL TREATMENT MODALITIES
por: Sumerauer, David, et al.
Publicado: (2023)

PATH-14. GENETIC SUSCEPTIBILITY AND OUTCOMES OF PEDIATRIC, ADOLESCENT AND YOUNG ADULT IDH-MUTANT ASTROCYTOMAS
por: Bornhorst, Miriam, et al.
Publicado: (2020)

PATH-04. AN ENHANCED AI-DRIVEN PLATFORM FOR PRECISION MOLECULAR BRAIN TUMOR DIANOSTICS
por: Sill, Martin, et al.
Publicado: (2020)

PATH-31. THE IMPACT OF MOLECULAR PROFILING OF PEDIATRIC CNS TUMORS ON TUMOR DIAGNOSIS AND MANAGEMENT - A SINGLE CENTER EXPERIENCE
por: Sabet, Kazuhiro, et al.
Publicado: (2020)

PATH-11. PROSPECTIVE (EPI-)GENETIC CLASSIFICATION OF > 1,000 PEDIATRIC CNS TUMORS—THE MNP 2.0 STUDY
por: Sturm, Dominik, et al.
Publicado: (2020)

PATH-26. RNA SEQUENCING OF FORMALIN-FIXED PARAFFIN-EMBEDDED SPECIMENS IN DIAGNOSTIC ROUTINE IDENTIFIES CLINICALLY RELEVANT GENE FUSIONS
por: Stichel, Damian, et al.
Publicado: (2020)

PATH-01. MOLECULAR PROFILING OF PAEDIATRIC CENTRAL NERVOUS SYSTEM TUMOURS IN AUSTRALASIA – AN UPDATE ON THE AIM BRAIN AND MNP2.0 PROJECTS
por: Algar, Elizabeth, et al.
Publicado: (2020)

PATH-21. TELOMERE LENGTH ANALYSIS OF CNS TUMORS IN THE PEDIATRIC BRAIN TUMOR ATLAS
por: Rokita, Jo Lynn, et al.
Publicado: (2020)

PATH-15. PROTEOMIC SIGNATURES PREDICT GRADE IN PEDIATRIC AND YOUNG ADULT INFILTRATIVE ASTROCYTOMAS
por: Graham, Richard T, et al.
Publicado: (2020)

PATH-18. HIGH-GRADE NEUROEPITHELIAL TUMOR (HGNET) IN A PEDIATRIC CASE-SERIES
por: Sanders, Felipe Hada, et al.
Publicado: (2020)

PATH-13. PLEOMORPHIC XANTHOASTROCYTOMA INTEGRATED GENOMIC CHARACTERIZATION - WHAT HAVE WE LEARNED?
por: Vaubel, Rachael, et al.
Publicado: (2020)

PATH-23. ADULT SPINAL CORD ASTROBLASTOMA WITH EWSR1-BEND2 FUSION
por: Tsutsui, Takeyoshi, et al.
Publicado: (2020)

PATH-10. PROGNOSTIC RELEVANT IMMUNOPHENOTYPES OF PEDIATRIC HIGH-GRADE NON-BRAINSTEM GLIOMAS
por: Mikhaleuskaya, Taisiya, et al.
Publicado: (2020)

PATH-06. IMAGE-BASED MACHINE LEARNING CLASSIFIER FOR PEDIATRIC POSTERIOR FOSSA TUMOR HISTOPATHOLOGY
por: Tam, Lydia, et al.
Publicado: (2020)

PATH-16. CORRELATION OF PATHOLOGICAL AND RADIOGRAPHICAL DIAGNOSES FOR CHILDREN WITH BRAIN TUMORS AT TWO MAJOR HOSPITAL IN KENYA
por: Okemwa, Dr Minda, et al.
Publicado: (2020)

PATH-22. COMPARISON OF SUPERVISED CLASSIFICATION METHODS FOR CENTRAL NERVOUS SYSTEM TUMORS BASED ON DNA-METHYLATION
por: Orr, Brent, et al.
Publicado: (2020)

PATH-30. EXOSOMES AS A SOURCE OF PLASMA ctDNA TO IDENTIFY POINT MUTATIONS IN PEDIATRIC GLIOMA PATIENTS
por: Nobre, Liana, et al.
Publicado: (2020)

PATH-08. THE IMPORTANCE OF RE-DIAGNOSIS OF TUMORS PREVIOUSLY CLASSIFIED AS CENTRAL NERVOUS SYSTEM PRIMITIVE NEUROECTODERMAL TUMORS
por: Fujita, Naohide, et al.
Publicado: (2020)

PATH-27. MUTATION DETECTION USING PLASMA CELL-FREE DNA IN CHILDREN WITH CENTRAL NERVOUS SYSTEM TUMORS
por: Mangum, Ross, et al.
Publicado: (2020)

PATH-25. GENOME-WIDE METHYLATION ANALYSIS CAN SEGREGATE RADIATION-INDUCED GLIOBLASTOMA FROM LATE RECURRENCE OF MEDULLOBLATOMAS
por: Hiraki, Takamasa, et al.
Publicado: (2020)

PATH-05. A CASE OF PILOCYTIC ASTROCYTOMA HARBORING THE FGFR1 GENE MUTATION WITH A PREDOMINANT OLIGODENDROGLIOMA-LIKE COMPONENT
por: Sasaki, Nobuyoshi, et al.
Publicado: (2020)

PATH-28. MOLECULAR DIAGNOSIS FOR CENTRAL DIAGNOSIS OF BRAIN TUMORS FROM 2016 TO 2019— A REPORT FROM THE JAPAN CHILDREN’S CANCER GROUP (JCCG)
por: Nakano, Yoshiko, et al.
Publicado: (2020)

PATH-24. MOLECULAR CLASSIFICATION OF HIGH RISK INFANT EMBRYONAL BRAIN TUMORS ENROLLED IN THE ACNS0334 TRIAL: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP
por: Li, Bryan K, et al.
Publicado: (2020)

PATH-09. SJMB12 CLINICAL TRIAL: DISCREPANCY BETWEEN LOCAL AND CENTRAL PATHOLOGY IN ASSESSING ANAPLASTIC MEDULLOBLASTOMA – REPORT FROM A SINGLE SITE EXPERIENCE
por: Khuong-Quang, Dong-Anh, et al.
Publicado: (2020)

PATH-17. INTRAGENIC COPY NUMBER BREAKPOINT ANALYSIS OF METHYLATION DATA FROM CNS TUMOURS IDENTIFIES NOVEL SUBGROUP-SPECIFIC CANDIDATE FUSION GENE ENRICHMENTS
por: Mackay, Alan, et al.
Publicado: (2020)

PATH-19. MOLECULAR CLASSIFICATION BASED ON THE DNA METHYLATION PROFILE OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS IN CHILDREN: TWO-YEARS EXPERIENCE AT THE BAMBINO GESÙ HOSPITAL
por: Miele, Evelina, et al.
Publicado: (2020)

PATH-07. QUALITY ASSURANCE IN CEREBROSPINAL FLUID CYTOLOGY ASSESSMENT FOR MEDULLOBLASTOMA STAGING LEADS TO POTENTIAL IMPROVED RISK-GROUP ASSESSMENT IN THE PROSPECTIVE MULTICENTER HIT-2000 TRIAL
por: Hagel, Christian, et al.
Publicado: (2020)

PATH-03. HIGH-GRADE NEUROEPITHELIAL TUMOR SHOWING BCOR IMMUNOPOSITIVITY WITHOUT EXON 15 INTERNAL TANDEM DUPLICATIONS IN A FIVE-YEAR-OLD BOY: A CASE REPORT
por: Wakita, Shogo, et al.
Publicado: (2020)

PATH-29. HIGH FREQUENCY OF CLINICALLY-RELEVANT TUMOR VARIANTS DETECTED BY MOLECULAR TESTING OF HIGH-RISK PEDIATRIC CNS TUMORS – PRELIMINARY FINDINGS FROM THE TEXAS KidsCanSeq STUDY
por: Lin, Frank Y, et al.
Publicado: (2020)

MIAT Is an Upstream Regulator of NMYC and the Disruption of the MIAT/NMYC Axis Induces Cell Death in NMYC Amplified Neuroblastoma Cell Lines
por: Feriancikova, Barbara, et al.
Publicado: (2021)

Mazabraud's syndrome: A case report supported by molecular studies and review of the literature
por: Kašpar, Ludvík, et al.
Publicado: (2023)

PATH-04. Array-based global DNA Methylation profiling of mouse brain tumors allows comparison to human tumors
por: Schoof, Melanie, et al.
Publicado: (2022)

Older age is a protective factor for academic achievements irrespective of treatment modalities for posterior fossa brain tumours in children
por: Kruseova, Jarmila, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9rc9j5gslioiqo0fkqgceujls9